DR.Guttler’s Patient Thyroid Blog Post: Infants at risk for thyroid dysfunction after contrast dye testing. Dr.Guttler’s comments: 1. 3,481 patients under 3 years of age who were exposed to ICM, thyroid dysfunction was reported in...
More infoHow A PET/CT Study Saved A Patient From Unnecessary Thyroid Surgery with a Class III atypical cytology and suspicious AFIRMA classifier.
50 Y/O female with a large thyroid nodule who was told to have surgery after the FNA was class III atypical cells, and a AFIRMA GSC classifier suspicious.She was told she had a 50% chance of cancer. She had the nodular goiter for years 2004. She...
More infoPET/CT Use to Separate the benign suspicious Thyroid Nodule from the Suspicious Cancer nodule.
Indeterminate thyroid nodules. The role of 18F-FDG PET/CT in the “era” of ultrasonography risk stratification systems and new thyroid cytology classifications Arnoldo Piccardo, et al Endocrine volume 69, pages 553–561 (2020 DR.Guttler’s...
More infoYes, We can Treat Follicular Neoplasm FN with Thyroid RFA
The use of PET/CT in follicular neoplasms has been shown to sort out two groups. 28 / 86 patients with FN had PET/CT imaging. 6/28 had high SUV max of >5. and sent to surgery. 22/28 had low SUV max> 5. All 22 had thyroid RF ablation. 12 month...
More infoMore Uses for Thyroid RFA: Minimally Invasive Follicular Neoplasms FN
A 5 year study by Ha on 10 patients with FN <2 cm found RFA safe and effective in these neoplasms. 8/10 the nodule total ablation. No recurrences at 5 years. Call me for a consultation if you want information if RFA is right for you.We are...
More info